24 - 25 March, 2025 I Millennium Gloucester Hotel and Conference Centre, London
Cresilon
Cresilon is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices utilizing the company’s proprietary hydrogel technology. The company’s plant- based technology is designed to control bleeding in trauma care, biosurgery, and animal health. TRAUMAGEL is the first hemostatic gel designed for controlling moderate to severe bleeding.
Website: https://cresilon.com/
In Partnership With :
QUESTIONS?
Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 1135 210 042
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk
©2024 IQPC. All rights reserved.
